Northern Trust
HRMY icon

Northern Trust’s Harmony Biosciences HRMY Stock Holding History

Northern Trust’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2M Buy
471,221
+47,992
+11% +$1.51M ﹤0.01% 1889
2026
Q1 		$11.9M Buy
423,229
+4,291
+1% +$141K ﹤0.01% 1976
2025
Q4 		$15.7M Sell
418,938
-13,823
-3% -$454K ﹤0.01% 1827
2025
Q3 		$11.9M Sell
432,761
-1,174
-0.3% -$40.4K ﹤0.01% 2015
2025
Q2 		$13.7M Buy
433,935
+30,393
+8% +$978K ﹤0.01% 1883
2025
Q1 		$13.4M Sell
403,542
-920
-0.2% -$33K ﹤0.01% 1871
2024
Q4 		$13.9M Buy
404,462
+110,345
+38% +$3.79M ﹤0.01% 1934
2024
Q3 		$11.8M Sell
294,117
-13,151
-4% -$462K ﹤0.01% 1971
2024
Q2 		$9.27M Sell
307,268
-16,246
-5% -$489K ﹤0.01% 2037
2024
Q1 		$10.9M Sell
323,514
-8,002
-2% -$257K ﹤0.01% 1985
2023
Q4 		$10.7M Sell
331,516
-12,795
-4% -$357K ﹤0.01% 2020
2023
Q3 		$11.3M Buy
344,311
+12,027
+4% +$418K ﹤0.01% 1912
2023
Q2 		$11.7M Buy
332,284
+58,018
+21% +$2M ﹤0.01% 1943
2023
Q1 		$8.95M Sell
274,266
-588
-0.2% -$26.8K ﹤0.01% 2093
2022
Q4 		$15.1M Buy
274,854
+5,837
+2% +$321K ﹤0.01% 1727
2022
Q3 		$11.9M Buy
269,017
+14,487
+6% +$707K ﹤0.01% 1859
2022
Q2 		$12.4M Buy
254,530
+21,396
+9% +$963K ﹤0.01% 1866
2022
Q1 		$11.3M Sell
233,134
-7,690
-3% -$314K ﹤0.01% 2070
2021
Q4 		$10.3M Buy
240,824
+28,516
+13% +$1.14M ﹤0.01% 2213
2021
Q3 		$8.14M Buy
212,308
+22,187
+12% +$714K ﹤0.01% 2431
2021
Q2 		$5.37M Buy
190,121
+121,335
+176% +$3.64M ﹤0.01% 2798
2021
Q1 		$2.27M Sell
68,786
-5,427
-7% -$190K ﹤0.01% 3172
2020
Q4 		$2.68M Buy
+74,213
New +$3M ﹤0.01% 3041

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust's HRMY Position: Q2 2026 in Review

Northern Trust increased its Harmony Biosciences (HRMY) stake by 11% in Q2 2026, buying an estimated $1.51M and bringing the position to 471,221 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1889.

Northern Trust first reported a position in HRMY in Q4 2020 and has held it in 23 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Northern Trust held 471,221 shares of Harmony Biosciences worth $17.2M as of Q2 2026.
  • Northern Trust bought 47,992 Harmony Biosciences shares in Q2 2026, an estimated $1.51M.
  • Harmony Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1889 holding.
  • Northern Trust first reported a position in Harmony Biosciences in Q4 2020 and has held it in 23 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.